Literature DB >> 25990814

HIV reservoirs as obstacles and opportunities for an HIV cure.

Tae-Wook Chun1, Susan Moir1, Anthony S Fauci1.   

Abstract

The persistence of HIV reservoirs remains a formidable obstacle to achieving sustained virologic remission in HIV-infected individuals after antiretroviral therapy (ART) is discontinued, even if plasma viremia has been successfully suppressed for prolonged periods of time. Numerous approaches aimed at eradicating the virus, as well as maintaining its prolonged suppression in the absence of ART, have had little success. A better understanding of the pathophysiologic nature of HIV reservoirs and the impact of various interventions on their persistence is essential for the development of successful therapeutic strategies against HIV or the long-term control of infection. Here, we discuss the persistent HIV reservoir as a barrier to cure as well as the current therapeutic strategies aimed at eliminating or controlling the virus in the absence of ART.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25990814     DOI: 10.1038/ni.3152

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  62 in total

1.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

2.  Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir.

Authors:  Tae-Wook Chun; Danielle Murray; Jesse S Justement; Jana Blazkova; Claire W Hallahan; Olivia Fankuchen; Kathleen Gittens; Erika Benko; Colin Kovacs; Susan Moir; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

3.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  HIV-1 vaccines and adaptive trial designs.

Authors:  Lawrence Corey; Gary J Nabel; Carl Dieffenbach; Peter Gilbert; Barton F Haynes; Margaret Johnston; James Kublin; H Clifford Lane; Giuseppe Pantaleo; Louis J Picker; Anthony S Fauci
Journal:  Sci Transl Med       Date:  2011-04-20       Impact factor: 17.956

Review 5.  Histone deacetylase inhibitors and HIV latency.

Authors:  David M Margolis
Journal:  Curr Opin HIV AIDS       Date:  2011-01       Impact factor: 4.283

6.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Authors:  Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

7.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

Review 8.  A Blueprint for HIV Vaccine Discovery.

Authors:  Dennis R Burton; Rafi Ahmed; Dan H Barouch; Salvatore T Butera; Shane Crotty; Adam Godzik; Daniel E Kaufmann; M Juliana McElrath; Michel C Nussenzweig; Bali Pulendran; Chris N Scanlan; William R Schief; Guido Silvestri; Hendrik Streeck; Bruce D Walker; Laura M Walker; Andrew B Ward; Ian A Wilson; Richard Wyatt
Journal:  Cell Host Microbe       Date:  2012-10-18       Impact factor: 21.023

9.  Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.

Authors:  Dan H Barouch; James B Whitney; Brian Moldt; Florian Klein; Thiago Y Oliveira; Jinyan Liu; Kathryn E Stephenson; Hui-Wen Chang; Karthik Shekhar; Sanjana Gupta; Joseph P Nkolola; Michael S Seaman; Kaitlin M Smith; Erica N Borducchi; Crystal Cabral; Jeffrey Y Smith; Stephen Blackmore; Srisowmya Sanisetty; James R Perry; Matthew Beck; Mark G Lewis; William Rinaldi; Arup K Chakraborty; Pascal Poignard; Michel C Nussenzweig; Dennis R Burton
Journal:  Nature       Date:  2013-10-30       Impact factor: 49.962

10.  Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.

Authors:  Steven A Yukl; Eli Boritz; Michael Busch; Christopher Bentsen; Tae-Wook Chun; Daniel Douek; Evelyn Eisele; Ashley Haase; Ya-Chi Ho; Gero Hütter; J Shawn Justement; Sheila Keating; Tzong-Hae Lee; Peilin Li; Danielle Murray; Sarah Palmer; Christopher Pilcher; Satish Pillai; Richard W Price; Meghan Rothenberger; Timothy Schacker; Janet Siliciano; Robert Siliciano; Elizabeth Sinclair; Matt Strain; Joseph Wong; Douglas Richman; Steven G Deeks
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

View more
  104 in total

1.  Pharmacokinetic stability of macrocyclic peptide triazole HIV-1 inactivators alone and in liposomes.

Authors:  Rachna Aneja; Antonella Grigoletto; Aakansha Nangarlia; Adel A Rashad; Steven Wrenn; Jeffrey M Jacobson; Gianfranco Pasut; Irwin Chaiken
Journal:  J Pept Sci       Date:  2019-02-27       Impact factor: 1.905

2.  Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA.

Authors:  Julio C C Lorenzi; Yehuda Z Cohen; Lillian B Cohn; Edward F Kreider; John P Barton; Gerald H Learn; Thiago Oliveira; Christy L Lavine; Joshua A Horwitz; Allison Settler; Mila Jankovic; Michael S Seaman; Arup K Chakraborty; Beatrice H Hahn; Marina Caskey; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-21       Impact factor: 11.205

3.  Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.

Authors:  Caroline Pereira Bittencourt Passaes; Timothée Bruel; Jérémie Decalf; Annie David; Mathieu Angin; Valerie Monceaux; Michaela Muller-Trutwin; Nicolas Noel; Katia Bourdic; Olivier Lambotte; Matthew L Albert; Darragh Duffy; Olivier Schwartz; Asier Sáez-Cirión
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

4.  The mTOR Complex Controls HIV Latency.

Authors:  Emilie Besnard; Shweta Hakre; Martin Kampmann; Hyung W Lim; Nina N Hosmane; Alyssa Martin; Michael C Bassik; Erik Verschueren; Emilie Battivelli; Jonathan Chan; J Peter Svensson; Andrea Gramatica; Ryan J Conrad; Melanie Ott; Warner C Greene; Nevan J Krogan; Robert F Siliciano; Jonathan S Weissman; Eric Verdin
Journal:  Cell Host Microbe       Date:  2016-12-14       Impact factor: 21.023

5.  Development and characterization of a long-acting nanoformulated abacavir prodrug.

Authors:  Dhirender Singh; JoEllyn McMillan; James Hilaire; Nagsen Gautam; Diana Palandri; Yazen Alnouti; Howard E Gendelman; Benson Edagwa
Journal:  Nanomedicine (Lond)       Date:  2016-07-26       Impact factor: 5.307

6.  IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.

Authors:  Rui André Saraiva Raposo; Miguel de Mulder Rougvie; Dominic Paquin-Proulx; Phillip M Brailey; Vinicius D Cabido; Paul M Zdinak; Allison S Thomas; Szu-Han Huang; Greta A Beckerle; Richard B Jones; Douglas F Nixon
Journal:  JCI Insight       Date:  2017-01-12

7.  Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization.

Authors:  Valentina Cecchinato; Enos Bernasconi; Roberto F Speck; Michele Proietti; Ulrike Sauermann; Gianluca D'Agostino; Gabriela Danelon; Tanja Rezzonico Jost; Fabio Grassi; Lorenzo Raeli; Franziska Schöni-Affolter; Christiane Stahl-Hennig; Mariagrazia Uguccioni
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

8.  Kinetics of Plasma HIV Rebound in the Era of Modern Antiretroviral Therapy.

Authors:  Michael C Sneller; Erin D Huiting; Katherine E Clarridge; Catherine Seamon; Jana Blazkova; Jesse S Justement; Victoria Shi; Emily J Whitehead; Rachel F Schneck; Michael Proschan; Susan Moir; Anthony S Fauci; Tae-Wook Chun
Journal:  J Infect Dis       Date:  2020-10-13       Impact factor: 5.226

9.  Elucidating the Burden of HIV in Tissues Using Multiplexed Immunofluorescence and In Situ Hybridization: Methods for the Single-Cell Phenotypic Characterization of Cells Harboring HIV In Situ.

Authors:  Joshua J Vasquez; Rajaa Hussien; Brandon Aguilar-Rodriguez; Henrik Junger; Dejan Dobi; Timothy J Henrich; Cassandra Thanh; Erica Gibson; Louise E Hogan; Joseph McCune; Peter W Hunt; Cheryl A Stoddart; Zoltan G Laszik
Journal:  J Histochem Cytochem       Date:  2018-02-20       Impact factor: 2.479

Review 10.  Bispecific antibodies: Potential immunotherapies for HIV treatment.

Authors:  Giulia Fabozzi; Amarendra Pegu; Richard A Koup; Constantinos Petrovas
Journal:  Methods       Date:  2018-10-22       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.